THE HETEROGENEITY OF THE INTERACTION BETWEEN CANCER CHEMOTHERAPEUTIC AGENTS AND HOST RESISTANCE MECHANISMSSPREAFICO F.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 75; PP. 200-206; BIBL. 15 REF.Article

US OF LEVAMISOLE IN CANCER PATIENTSSPREAFICO F.1980; DRUGS; CHE; DA. 1980; VOL. 20; NO 2; PP. 105-116; BIBL. 29 REF.Article

BIOLOGICAL ACTIVITIES OF ANTILYMPHOCYTIC SERUMSPREAFICO F.1972; ADV. PHARMACOL. CHEMOTHERAPY; U.S.A.; DA. 1972; VOL. 10; PP. 257-338; BIBL. 14P.1/2Serial Issue

Immunotoxicology in 1987: problems and challengesSPREAFICO, F.Fundamental & clinical pharmacology. 1988, Vol 2, Num 4, pp 353-367, issn 0767-3981Article

ON THE NATURE OF BLOCKING FACTORS AND THEIR LYMPHOID TARGET CELLS IN AN ALLOGENEIC TUMOR SYSTEM. = SUR LA NATURE DES FACTEURS BLOQUANT ET LEURS CELLULES CIBLES LYMPHOIDES DANS LE SYSTEME DE TUMEUR ALLOGENIQUEMANTOVANI A; SPREAFICO F.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 6; PP. 451-455; BIBL. 18 REF.Article

Problems and challenges in the use of immunomodulating agents: a general introductionSPREAFICO, F.International archives of allergy and applied immunology. 1985, Vol 76, pp 108-118, issn 0020-5915, suppl. 1Conference Paper

ALLOGENEIC TUMOR ENHANCEMENT BY LEVAMISOLE, A NEW IMMUNOSTIMULATORY COMPOUND: STUDIES ON CELL-MEDIATED IMMUNITY AND HUMORAL ANTIBODY RESPONSE.MANTOVANI A; SPREAFICO F.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 8; PP. 537-544; BIBL. 2 P.Article

THE IMMUNODEPRESSIVE AND HEMATOTOXIC ACTIVITIES OF N-TRIFLUORO-ACETYL-ADRIAMYCIN-14-VALERATEVECCHI A; SPREAFICO F; SIRONI M et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 10; PP. 1289-1296; BIBL. 27 REF.Article

EFFECT OF THE COMBINATION OF CORYNEBACTERIUM PARVUM AND LEVAMISOLE ON MURINE TUMORS.ANACLERIO A; CONTI G; MORAS ML et al.1977; EUROP. J. CANCER; G.B.; DA. 1977; VOL. 13; NO 12; PP. 1451-1453; BIBL. 12 REF.Article

ADJUVANT TREATMENT WITH LEVAMISOLE IN CANCER. A REVIEW OF EXPERIMENTAL AND CLINICAL DATA.AMERY WK; SPREAFICO F; ROJAS AF et al.1977; CANCER TREATM. REV.; G.B.; DA. 1977; VOL. 4; NO 3; PP. 167-194; BIBL. 5 P.Article

EFFECT OF CORYNEBACTERIUM PARVUM ON CELLULAR AND HUMORAL ANTITUMORAL IMMUNE EFFECTOR MECHANISMSMANTOVANI A; TOGLIABUE A; VECCHI A et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 2; PP. 113-123; BIBL. 2 P. 1/2Article

Workshop summary: animal tumor models for evaluating chemically defined immunomodulatorsHADDEN, J. W; SPREAFICO, F.Advances in experimental medicine and biology. 1983, Vol 166, pp 309-315, issn 0065-2598Article

METASTATIC POTENTIAL OF METASTASES, TUMOR CELL HETEROGENEITY, AND THERAPEUTIC IMPLICATIONSSPREAFICO F; MANTOVANI A; GIAVAZZI R et al.1982; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1982; NO 80; PP. 1-8; BIBL. 14 REF.Article

IN VIVO AND IN VITRO IMMUNOSUPPRESSIVE EFFECT OF TWO BATROXOBIN PREPARATIONS IN MICEANACCERIO A; RUGGERI A; POGGI A et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 1-2; PP. 253-258; BIBL. 17 REF.Article

EFFECT OF CHEMOTHERAPEUTIC AGENTS ON NATURAL CELL-MEDIATED CYTOTOXICITY IN MICEMANTOVANI A; LUINI W; PERI G et al.1978; J. NATION. CANCER INST.; USA; DA. 1978; VOL. 61; NO 5; PP. 1255-1261; BIBL. 41 REF.Article

EFFETTO ANTITUMORALE ED ANTIMETASTASICO DEL TRATTAMENTO COMBINATO DI "CORYNEBACTERIUM PARVUM" E LEVAMISOLE IN TUMORI SPERIMENTALI MURINI. = EFFET ANTITUMORAL ET ANTIMETASTATIQUE DU TRAITEMENT ASSOCIE PAR C.P. ET LEVAMISOLE DANS LES TUMEURS EXPERIMENTALES MURINESANACLERIO A; BARALE C; CONTI G et al.1977; FOLIA ALLERGOL. IMMUNOL. CLIN.; ITAL.; DA. 1977; VOL. 24; NO 2; PP. 201-203; ABS. ANGL.; BIBL. 6 REF.Article

ANTIGENIC CHANGES OF L5178Y LYMPHOMA AFTER TREATMENT WITH 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE IN VIVONICOLIN A; SPREAFICO F; BONMASSAR E et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 56; NO 1; PP. 89-93; BIBL. 16 REF.Article

New strategies of immunotherapyHADDEN, J. W; SPREAFICO, F.Springer seminars in immunopathology. 1985, Vol 8, Num 4, pp 321-326, issn 0344-4325Article

METASTASIZING CAPACITY OF TUMOUR CELLS FROM SPONTANEOUS METASTASES OF TRANSPLANTED MURINE TUMOURSGIAVAZZI R; ALESSANDRI G; SPREAFICO F et al.1980; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1980; VOL. 42; NO 3; PP. 462-472; BIBL. 21 REF.Article

A CHARACTERIZATION OF THE IMMUNOSUPPRESSIVE ACTIVITY OF ADRIAMYCIN AND DAUNOMYCIN ON HUMORAL ANTIBODY PRODUCTION AND TUMOR ALLOGRAFT REJECTIONVECCHI A; MANTOVANI A; TAGLIABUE A et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 4; PP. 1222-1227; BIBL. 42 REF.Article

INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN AINTRONA M; ALLAVENA P; SPREAFICO F et al.1981; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1981; VOL. 31; NO 2; PP. 113-116; BIBL. 25 REF.Article

ANTITUMORAL EFFECT IN MICE OF A NEW TRIEPOXYDE DERIVATIVE: 1,3,5-TRIGLYCIDYL-5-TRIAZINETRIONE (NSC 296934)ATASSI G; SPREAFICO F; DUMONT P et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 12; PP. 1561-1567; BIBL. 11 REF.Article

EFFECT OF IMMUNOMODULATORS ON THYMOCYTE SUPPRESSIVE ACTIVITY IN MICE.ANACLERIO A; CONTI G; MORAS ML et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 8; PP. 829-835; BIBL. 27 REF.Article

HUMAN MATURE MACROPHAGES MEDIATE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ON TUMOUR CELLS.MANTOVANI A; CAPRIOLI V; GRITTI P et al.1977; TRANSPLANTATION; U.S.A.; DA. 1977; VOL. 24; NO 4; PP. 291-293; BIBL. 16 REF.Article

IL MECCANISMO D'AZIONE DEL CORYNEBACTERIUM PARVUM E SUE CONSEGUENZE PER TRATTAMENTI IMMUNOTERAPICI. = MECANISME D'ACTION DE C.P. ET SES CONSEQUENCES POUR L'IMMUNOTHERAPIEVECCHI A; TAGLIABUE A; MANTOVANI A et al.1977; FOLIA ALLERGOL. IMMUNOL. CLIN.; ITAL.; DA. 1977; VOL. 24; NO 2; PP. 242-244; ABS. ANGL.; BIBL. 4 REF.Article